These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24288386)

  • 1. Compositional differences in commercially available prothrombin complex concentrates.
    Sadeghi N; Kahn D; Sayed D; Hoppenstadt D; Jeske W; Harenberg J; Dechristopher P; Fareed J
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):256-69. PubMed ID: 24288386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical comparison of seven commercially available prothrombin complex concentrates.
    Kalina U; Bickhard H; Schulte S
    Int J Clin Pract; 2008 Oct; 62(10):1614-22. PubMed ID: 18691229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication.
    Sadeghi N; Kahn D; Jeske W; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2013; 19(6):589-99. PubMed ID: 23463187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Factor VIIa-Mediated Activation of Prothrombin Complex Concentrates.
    Sadeghi N; Iacobelli M; Vaziri B; Kahn D; Hoppensteadt D; Guler N; Fareed J
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):211-220. PubMed ID: 27553841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro investigation of prothrombin complex concentrates.
    Römisch J; Bonik K; Müller HG
    Semin Thromb Hemost; 1998; 24(2):175-81. PubMed ID: 9579640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative use of prothrombin complex concentrates.
    Colomina MJ; Díez Lobo A; Garutti I; Gómez-Luque A; Llau JV; Pita E
    Minerva Anestesiol; 2012 Mar; 78(3):358-68. PubMed ID: 22357373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of prothrombin complex concentrates in China.
    Cao H; Tian Q; Huang Y; Ye S; Xin Y; Lin F; Li C
    Biologicals; 2015 Mar; 43(2):84-91. PubMed ID: 25648383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study.
    Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C
    J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and differentiation of active and inactive isoforms of coagulation factors II, VII, IX, and X in prothrombin complex concentrate by mass spectrometry.
    Wilhelm C; Kiessig ST; Mandago M; Wittke S
    J Pharm Biomed Anal; 2022 Feb; 209():114475. PubMed ID: 34839053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M; Béguin S; Hemker HC
    Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.
    Staudinger T; Frass M; Rintelen C; Quehenberger P; Wagner O; Stoiser B; Locker GJ; Laczika K; Knapp S; Watzke H
    Intensive Care Med; 1999 Oct; 25(10):1105-10. PubMed ID: 10551966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.
    Grottke O; Rossaint R; Henskens Y; van Oerle R; Ten Cate H; Spronk HM
    PLoS One; 2013; 8(5):e64100. PubMed ID: 23696866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.
    Ostermann H; Haertel S; Knaub S; Kalina U; Jung K; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):790-7. PubMed ID: 17938803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.